Pfizer’s major prescription pharmaceutical products in Canada include the following:
Pfizer Canada R&D Investments
Since the acquisition of Warner-Lambert Company in 2000, Pharmacia Corporation in 2003, Wyeth in 2009, Microtek in 2010 and King Pharmaceuticals in 2011, Pfizer has become one of the world’s largest companies based on market capitalization, reinforcing its leadership position in every major pharmaceutical market. Pfizer invests in a wide range of therapeutic areas, including arthritis, cardiovascular disease, endocrinology, infectious disease, neurological disease, oncology and ophthalmology and smoking cessation.
Pfizer Canada is a leader in Canadian healthcare research, investing an average of $150 million in research and development activities, contributions and partnerships. The company has invested more than $1 billion in R&D since 2000.
Pfizer's diversified health care portfolio includes human biologic and small molecule medicines and vaccines, as well as nutritional products and many of the world's best-known consumer products. Every day, Pfizer Canada employees work to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. We apply science and our global resources to improve the health and well-being of Canadians at every stage of life. Our commitment is reflected in everything Pfizer does, from our disease awareness initiatives to our community partnerships, to our belief that it takes more than medication to be truly healthy. Pfizer opened its first Canadian operations in 1953 in Montreal, Quebec.
Pfizer in the Community
As a major corporate donor in Canada, Pfizer Canada is a proud member of Imagine Canada and its Caring Company program. Pfizer Canada’s Community Investment Program supports more than 1,300 non-profit organizations and projects across the country with a total investment exceeding $38 million. Pfizer Canada is a major contributor to Health Partners International of Canada (HPIC). Since 1994, Pfizer Canada has donated close to $45 million in essential medicines to HPIC for the developing world. As a major corporate partner of the Canadian Paralympic Team, Pfizer Canada takes great pride in the athletes’ remarkable achievements, both at the Paralympic Games and at the game of life.
Pfizer Canada is dedicated to improving the health and quality of life of Canadians by investing in our communities. We are working together for a healthier world so that Canadians in the present and future generations not only live longer, but do so in good health and as productively as possible. At Pfizer Canada, we are proud to be a world-respected company who provides important medications that help manage health conditions, contribute to saving lives and make Canadians feel better.
We also recognize that it takes More than Medication to be truly healthy and it is our belief that, in addition to offering innovative medicines, we have a commitment to helping Canadians live healthier, balanced lives. This belief is reflected in everything we do at Pfizer Canada, from our disease awareness efforts to our community partnerships.
As a company, we’re committed to working together for a healthier world for Canadians and their communities. Today, tomorrow and for years to come.